Category: Ultrasound/Imaging
Poster Session II
Identifying patients at risk for spontaneous preterm birth (sPTB) remains a challenge because most have no history. For patients with a singleton gestation and no history of sPTB, some institutions offer universal cervical length (CL) screening via transvaginal ultrasound (TVUS). Those with a CL ≤ 25mm may receive vaginal progesterone (VP). Patients with an intermediate CL (26 – 29mm) also have increased risk for sPTB, however there are no management recommendations. This study aims to determine an appropriate TVUS follow-up (f/u) interval for patients with an intermediate CL.
Study Design:
This is a 5 year retrospective cohort of patients with a singleton gestation, no sPTB history, an intermediate CL seen during CL screening, and with ≥1 f/u TVUS at ≤ 24 6/7 weeks gestation. The primary outcome measure is incidence of short cervix.
Results:
An intermediate CL was found in 157 patients. 61 (38%) had no sPTB history and ≥1 f/u TVUS. The mean f/u interval was 18.3 ± 10.0 days, with 77 total f/u TVUS. At follow up, 19 patients (31%) were diagnosed with short cervix ≤ 25mm, with the mean time to diagnosis of 18.0 ± 8.0 days. The f/u intervals with the greatest yield was 15 – 21 days and 22 – 28 days, with 6 (30.0%) and 5 (41.7%) patients respectively diagnosed with short cervix (Figure 1). Compared to a 14 day f/u interval, significantly more patients with a short cervix were identified within 28 days [7 (36.84%) vs. 18 (94.7%), p < .001] (Figure 2). The mean delta CL was -2.4mm. Two patients progressed to a severely short cervix ( < 10mm). Of those diagnosed with short cervix, 12 (63.2%) started VP and 7 (36.8%) did not. No patients with VP delivered < 37 weeks gestation, and 1 patient without VP delivered at 36 5/7 weeks gestation.
Conclusion:
In patients with no history of sPTB and an intermediate CL, 31% will progress to short cervix and may be VP candidates. Given that 94.7% of those patients with a short cervix were identified within a 28 day f/u interval, a single f/u TVUS 3-4 weeks after the initial study will allow for identification of these patients and for appropriate intervention.
Carolyn Chatterton, DO, MPH
Maternal Fetal Medicine Fellow
Perinatology Research Branch, NICHD/NIH/DHHS
Detroit, Michigan, United States
Lina Fouad, MD
Wayne State University
Detroit, Michigan, United States
Sara Koussa, BSc
Wayne State University
Detroit, Michigan, United States
Bernard Gonik, MD
Wayne State University
Detroit, Michigan, United States